Clinty Chemicals Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: NI012138

Clinty Chemicals Limited

Filleted Financial Statements

31 August 2025

Clinty Chemicals Limited

Statement of Financial Position

31 August 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	5	1,964,617	2,299,948
Investments	6	88	88
		------------	------------
		1,964,705	2,300,036

Current assets

Stocks		2,573,793	2,794,157
Debtors	7	4,848,893	2,151,265
Cash at bank and in hand		1,049,821	980,012
		------------	------------
		8,472,507	5,925,434

Creditors: amounts falling due within one year	8	2,883,748		1,485,090
		------------		------------
Net current assets			5,588,759	4,440,344
			------------	------------
Total assets less current liabilities			7,553,464	6,740,380

Creditors: amounts falling due after more than one year	9		22,319	100,354

Provisions

Taxation including deferred tax	351,492	420,420
	------------	------------
Net assets	7,179,653	6,219,606
	------------	------------

Clinty Chemicals Limited

Statement of Financial Position (continued)

31 August 2025

	2025		2024
Note	£	£	£

Capital and reserves

Called up share capital	10,526	10,526
Profit and loss account	7,169,127	6,209,080
	------------	------------
Shareholders funds	7,179,653	6,219,606
	------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements were approved by the board of directors and authorised for issue on 28 November 2025 , and are signed on behalf of the board by:

Mr J Stevenson

Director

Company registration number: NI012138

Clinty Chemicals Limited

Notes to the Financial Statements

Year ended 31 August 2025

1. General information

The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 27 Duncrue Street, Belfast, BT3 9AR.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Deferred tax is provided in full on timing differences which result in an obligation at the balance sheet date to pay more tax, or a right to pay less tax, at a future date, at rates expected to apply when they crystallise based on current tax rates and law. Timing differences arise from the inclusion of items of income and expenditure in taxation computations in periods different from those in which they are included in the financial statements. Deferred tax assets are recognised to the extent that it is regarded as more likely than not that they will be recovered. Deferred tax assets and liabilities are not discounted.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Freehold Property	-	2% straight line
Plant and Machinery	-	6% straight line
Fixtures and Fittings	-	20% straight line
Motor Vehicles	-	20% straight line

	Equipment	-	33 % straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 13 (2024: 13 ).

5. Tangible assets

	Land and buildings	Plant and machinery	Fixtures and fittings	Motor vehicles	Equipment	Total
	£	£	£	£	£	£
Cost
At 1 Sep 2024	559,994	3,455,679	97,452	140,755	24,124	4,278,004
Additions	8,245	411,667	21,487	–	92,767	534,166
Disposals	–	( 910,122)	( 25,000)	–	–	( 935,122)
Transfers	–	(60,448)	60,448	–	–	–
	---------	------------	---------	---------	---------	------------
At 31 Aug 2025	568,239	2,896,776	154,387	140,755	116,891	3,877,048
	---------	------------	---------	---------	---------	------------
Depreciation
At 1 Sep 2024	131,937	1,757,596	25,074	51,314	12,135	1,978,056
Charge for the year	15,423	164,071	32,807	27,131	17,505	256,937
Disposals	–	( 318,395)	( 4,167)	–	–	( 322,562)
	---------	------------	---------	---------	---------	------------
At 31 Aug 2025	147,360	1,603,272	53,714	78,445	29,640	1,912,431
	---------	------------	---------	---------	---------	------------
Carrying amount
At 31 Aug 2025	420,879	1,293,504	100,673	62,310	87,251	1,964,617
	---------	------------	---------	---------	---------	------------
At 31 Aug 2024	428,057	1,698,083	72,378	89,441	11,989	2,299,948
	---------	------------	---------	---------	---------	------------

6. Investments

	Shares in group undertakings
	£
Cost
At 1 September 2024 and 31 August 2025	88
	----
Impairment
At 1 September 2024 and 31 August 2025	–
	----

Carrying amount
At 31 August 2025	88
	----
At 31 August 2024	88
	----

Relates to 100% shareholding in subsidiary undertaking Clinty Chemicals (Ireland) Limited

7. Debtors

	2025	2024
	£	£
Trade debtors	2,563,251	935,204
Amounts owed by group and related undertakings	2,161,747	1,104,033
Other debtors	123,895	112,028
	------------	------------
	4,848,893	2,151,265
	------------	------------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Bank loans and overdrafts	69,600	69,600
Trade creditors	2,063,215	412,138
Amounts owed to group and related undertakings	175,604	175,604
Social security and other taxes	253,642	246,344
Other creditors	321,687	581,404
	------------	------------
	2,883,748	1,485,090
	------------	------------

9. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Bank loans and overdrafts	22,319	100,354
	--------	---------

10. Contingencies

In past years the company received grant income from Invest Northern Ireland for a effluent treatment project. In the event of a default, Invest NI can demand repayment of the aggregate payments made to the company in a five year period prior to such an event occurs.

11. Summary audit opinion

The auditor's report dated 28 November 2025 was unqualified .

The senior statutory auditor was Michael Flannigan , for and on behalf of FEB Chartered Accountants .

12. Directors' advances, credits and guarantees

At the year end the company owed the directors £nil (2024: £nil).

13. Related party transactions

The company was jointly controlled by the Wilson and Stevenson families throughout the current and previous years. Balances with related parties at 31 August 2025 can be summarised as follows: Companies under control of the Wilson family: Wilson Resources Limited -amounts owed to related companies 175,604 Wilson Salt Limited -amounts owed by related companies (27,580) Wilson Salt Ireland Limited -amounts owed by related companies 3,226 Companies under control of the Stevenson family: James Stevenson (Quarries) Limited -amounts owed to related companies 87,313 Companies under the joint control of the Wilson and the Stevenson families: Clinty Re-Gen Limited -amounts owed to group companies Nil Clinty Chemicals (Ireland) Limited -amounts due from group companies 488 Clinty Laboratories Limited -amounts due from group companies 1,133,252 Clinty Bio Limited - amounts due from group companies 563,573 Purafloc Limited - amounts due from group companies 488,788